Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., May 15, 2017 /PRNewswire/ —¬†Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported financial results for the first quarter ended March 31, 2017 and provided key business updates.